REGENXBIO Inc.

NASDAQ:RGNX

Biotechnology

Healthcare
$7.24 +1.97%

+$0.16 today

Market cap
$478.73M
Beta
1.03
P/E (TTM)
-1.5
EPS (TTM)
-$5.53
52W Low $5.46High $16.19

Volume 0.96M

Average 1.24M

Price history

REGENXBIO Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-35.64%

Period high

$15.98

Period low

$5.65

Latest

$7.24

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13GNov 10, 2026Nov 10, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
4Nov 3, 2026Nov 3, 2026
8-KOct 16, 2026Oct 16, 2026
SC 13GOct 13, 2026Oct 13, 2026
8-KSep 23, 2026Sep 23, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
3Aug 27, 2026Aug 27, 2026
4Aug 27, 2026Aug 27, 2026
8-KAug 25, 2026Aug 25, 2026

Competitors

Who does REGENXBIO Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RGNX's filings, answered from its disclosures.

What is the latest RGNX filing?

The latest filing shown is SC 13G dated Nov 10, 2026.

How many recent filings does RGNX have?

Intrinsic Alpha currently shows 20 recent filings for RGNX.